Drug abuse prevention

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·

---

Drugs

Drug type

Designer drugs Dissociative drug Hallucinogenic drugs Nonprescription drugs Nootropic drugs Pharmaceutical drug Psychedelic drug Psychoactive drug Prescription drugs

Drug usage

Adverse drug reaction Drug abstinance Drug administration methods Drug allergies Drug discrimination Drug induced congenital disorders Drug interactions Drug metabolism Epidemiology of drug use Recreational drug use

Drug abuse

Codependency Drug abuse liability Drug addiction Drug dependency Drug dosages Drug induced hallucinations Drug laws Drug legalization Drug overdoses Drug sensitivity Drug tolerance Drug usage attitudes Drug withdrawal Laxative abuse Intravenous drug use Illegal drug distribution Needle exchange programs Needle sharing Poly drug abuse

Drug treatment

DANOS Drug abuse psychology Drug abuse prevention Drug augmentation Drug education Drug rehabilitation Drug self administration Drug therapy Drug usage screening Psychopharmacology Self medication Side effects (drug)

Drug abuse prevention are drug education intervention aimed at reducing drug abuse. This is usually an aspect of primary mental health prevention.

In the area of substance-related harms, a number of prevention typologies have been proposed.

Gordon (1987) in the area of disease prevention, and later Kumpfer and Baxley (1997) in the area of substance use proposed a three-tiered preventive intervention classification system: universal, selective and indicated prevention. Amongst others, this typology has gained favour and is used by the US Institute of Medicine, the NIDA and the European Monitoring Centre for Drugs and Drug Addiction.

1. Universal prevention addresses the entire population (national, local community, school, district) and aim to prevent or delay the abuse of alcohol, tobacco, and other drugs. All individuals, without screening, are provided with information and skills necessary to prevent the problem.
2. Selective prevention focuses on groups whose risk of developing problems of alcohol abuse or dependence is above average. The subgroups may be distinguished by characteristics such as age, gender, family history, or economic status. For example, drug campaigns in recreational settings.
3. Indicated prevention involves a screening process, and aims to identify individuals who exhibit early signs of substance abuse and other problem behaviours. Identifiers may include falling grades among students, known problem consumption or conduct disorders, alienation from parents, school, and positive peer groups etc.

Outside the scope of this three-tier model is Environmental prevention. Environmental prevention approaches are typically managed at the regulatory or community level, and focus on interventions to deter drug consumption. Prohibition and bans (e.g. smoking workplace bans, alcohol advertising bans) may be viewed as the ultimate environmental restriction. However, in practice environmental preventions programmes embrace various initiatives at the macro and micro level, from government monopolies for alcohol sales, through roadside sobriety or drug tests, worker/pupil/student drug testing, increased policing in sensitive settings (near schools, at rock festivals), and legislative guidelines aimed at precipitating punishments (warnings, penalties, fines).

See also

• Early intervention
• Preventative medicine

References

• Kumpfer, K. L., and Baxley, G. B. (1997), 'Drug abuse prevention: What works?', National Institute on Drug Abuse, Rockville.